๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Discovery Labs announces FDA approval of Surfaxin (lucinactant) for prevention of respiratory distress syndrome


Book ID
114376890
Publisher
Elsevier Science
Year
2012
Weight
45 KB
Volume
2012
Category
Article
ISSN
1351-4210

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES